Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Fig. 2 depicts the mean changes in the aforementioned metabolites, as well as vitamin D metabolites, from before to after a single TPE procedure, with reference ranges indicated for each metabolite (P < .001 for all).
Source: Changes of Mineral Parameters From Before to After a Single Therapeutic Plasma Exchange Procedure. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Among these, 43 participants had undergone more than 3 TPE treatments previously, while 2 participants were enrolled during their first TPE treatment.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Therapeutic Plasma Exchange and Changes in Calcium, Phosphate, Parathyroid Hormone, and Fibroblast Growth Factor-23
Study design awaiting verification · The Journal of Clinical Endocrinology and Metabolism · 2026
Original publication title
Therapeutic Plasma Exchange and Changes in Calcium, Phosphate, Parathyroid Hormone, and Fibroblast Growth Factor-23
© The Author(s) 2025. Published by Oxford University Press on behalf of the Endocrine Society.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
This study examined changes in plasma and effluent levels of total calcium, phosphate, PTH, and FGF-23 in individuals undergoing TPE.
Source: ObjectiveAbstract: What methods does the paper describe?
Measurements were taken immediately before, immediately after, and at follow-up. Paired t tests compared the percentage changes in metabolites from pre: to post-TPE.
Source: MethodsAbstract: Context
Therapeutic plasma exchange (TPE) removes plasma proteins and other unwanted substances, causing nonspecific alterations of plasma components. A previous study showed an approximately 70% reduction in vitamin D metabolites following a single TPE treatment, prompting further investigation into TPE's effects on vitamin D regulators and metabolites: calcium, phosphate, parathyroid hormone (PTH), and fibroblast growth factor-23 (FGF-23).
Source: ContextAbstract: Results
Study participants (N = 42) had a mean age of 55 ± 16 years, 28 (67%) were female, and 32 (76%) were White. TPE led to acute changes in calcium (−9%; 95% CI, −11% to −8%), phosphate (−14%; −18% to −11%), and FGF-23 (−12%; −18% to −6%) concentrations. In contrast, PTH levels increased (91%; 63%-119%) from baseline to post-TPE. While most metabolites returned to baseline by the follow-up visit (median 4 [interquartile range, 3-7] days), nearly 25% of patients experienced persistent asymptomatic hypocalcemia.
This persistent calcium deficit was not fully corrected by continuous intravenous calcium gluconate infusions administered during the study, nor by the endogenously increased PTH levels.
Source: ResultsAbstract: Conclusion
These findings underscore the need for improved care protocols and vigilant monitoring of mineral metabolism in TPE patients, especially those receiving long-term treatment. Further research is warranted to understand the enduring effects of TPE on mineral metabolism and develop strategies to prevent complications.
Source: ConclusionAuthors’ abstract
Abstract
Context
Therapeutic plasma exchange (TPE) removes plasma proteins and other unwanted substances, causing nonspecific alterations of plasma components. A previous study showed an approximately 70% reduction in vitamin D metabolites following a single TPE treatment, prompting further investigation into TPE's effects on vitamin D regulators and metabolites: calcium, phosphate, parathyroid hormone (PTH), and fibroblast growth factor-23 (FGF-23).
Objective
This study examined changes in plasma and effluent levels of total calcium, phosphate, PTH, and FGF-23 in individuals undergoing TPE.
Methods
Measurements were taken immediately before, immediately after, and at follow-up. Paired t tests compared the percentage changes in metabolites from pre: to post-TPE.
Results
Study participants (N = 42) had a mean age of 55 ± 16 years, 28 (67%) were female, and 32 (76%) were White. TPE led to acute changes in calcium (−9%; 95% CI, −11% to −8%), phosphate (−14%; −18% to −11%), and FGF-23 (−12%; −18% to −6%) concentrations. In contrast, PTH levels increased (91%; 63%-119%) from baseline to post-TPE. While most metabolites returned to baseline by the follow-up visit (median 4 [interquartile range, 3-7] days), nearly 25% of patients experienced persistent asymptomatic hypocalcemia.
This persistent calcium deficit was not fully corrected by continuous intravenous calcium gluconate infusions administered during the study, nor by the endogenously increased PTH levels.
Conclusion
These findings underscore the need for improved care protocols and vigilant monitoring of mineral metabolism in TPE patients, especially those receiving long-term treatment. Further research is warranted to understand the enduring effects of TPE on mineral metabolism and develop strategies to prevent complications.
Publication and source details
Original title: Therapeutic Plasma Exchange and Changes in Calcium, Phosphate, Parathyroid Hormone, and Fibroblast Growth Factor-23
Sami SeungMi Jin; Anushree Dugar; Andrew N Hoofnagle; Amber P Sanchez; David M Ward; Joachim H Ix; Charles Ginsberg
The Journal of Clinical Endocrinology and Metabolism · 2026
Correspondence: Charles Ginsberg, MD, MAS, University of California San Diego, 9452 Medical Center Dr, L3E206, La Jolla, CA 92037, USA. Email: cginsberg@health.ucsd.edu.© The Author(s) 2025. Published by Oxford University Press on behalf of the Endocrine Society.2025https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. See the journal About page for additional terms. National Institute of Diabetes Digestive and Kidney Diseases10.13039/100000062 K23DK118197L30DK110882R01DK101720K24 DK110427 University of California San Diego10.13039/100007911 O’Brien Center for Acute Kidney Injury ResearchRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T00:19:50.458292+00:00
DOI: 10.1210/clinem/dgaf400 · PMC12819856